Inventor

STORCK PIERRE HENRI

FR43 patents

⚠️ This page may combine multiple inventors who share the name “STORCK PIERRE HENRI”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

STORCK PIERRE HENRI

VERTEX PHARMA

Compounds useful as inhibitors of ATR kinase

Compounds useful as inhibitors of ATR kinase

Compounds useful as inhibitors of ATR kinase

Compounds useful as inhibitors of ATR kinase

Compounds useful as inhibitors of ATR kinase

Compounds useful as inhibitors of ATR kinase

Compounds useful as inhibitors of ATR kinase

Compounds useful as inhibitors of ATR kinase

Compounds useful as inhibitors of ATR kinase

Compounds useful as inhibitors of ATR kinase

Compounds useful as inhibitors of ATR kinase

Compounds useful as inhibitors of ATR kinase

Compounds useful as inhibitors of ATR kinase

Compounds useful as inhibitors of ATR kinase

Compounds useful as inhibitors of ATR kinase

Compounds useful as inhibitors of ATR kinase

Compounds useful as inhibitors of ATR kinase

Compounds useful as inhibitors of ATR kinase

JANSSEN PHARMACEUTICA NV

Pyrido-and pyrimidopyrimidine derivatives as anti-profilerative agents

Inhibitors of the interaction between MDM2 and P53

Macrocyclic quinazole derivatives and their use as MTKI

Macrocyclic quinazole derivatives and their use as MTKI

Tetrahydrophenanthridinones and tetrahydrocyclopentaquinolinones as PARP and tubulin polymerization inhibitors

Tetrahydrophenanthridinones and tetrahydrocyclopentaquinolinones as parp and tubulin polymerization inhibitors

Pyrido and pyrimidopyrimidine derivatives as anti-profilerative agents

CHARRIER JEAN-DAMIEN

Compounds useful as inhibitors of ATR kinase

Aminopyrazines as ATR kinase inhibitors

Compounds useful as inhibitors of ATR kinase

MERCK PATENT GMBH

GCN2 inhibitors and uses thereof

GCN2 inhibitors and uses thereof

GCN2 inhibitors and uses thereof

STORCK PIERRE-HENRI

Substituted pyrrolo[2,3-b]pyrazines as ATR kinase inhibitors

Inhibitors of the interaction between MDM2 and p53

VIALARD JORGE EDUARDO

Quinolinone derivatives as PARP and TANK inhibitors

Quinolinone derivatives as PARP and tank inhibitors

EVERITT SIMON

Substituted pyrrolo[2,3-B]pyrazines as ATR kinase inhibitors

MACCORMICK SOMHAIRLE

Pyrrolo[2,3-B]pyrazines useful as inhibitors of ATR kinase

ANGIBAUD PATRICK RENE

Quinolinone derivatives as PARP inhibitors

FREYNE EDDY JEAN EDGARD

Pyrido-and pyrimidopyrimidine derivatives as anti-proliferative agents

PONCELET VIRGINIE SOPHIE

Inhibitors of the interaction between MDM2 and P53

Angibaud Patrick René

Tetrahydrophenanthridinones and tetrahydrocyclopentaquinolinones as PARP and tubulin polymerization inhibitors

PAPANIKOS ALEXANDRA

MTKI quinazoline derivatives

PONCELET ALAIN PHILIPPE

Substituted phenylenediamines as inhibitors of the interaction between MDM2 and P53